Passage Bio Inc (PASG)

Schlusskurs vom Vortag:

$1.31

Offen:

$1.33

24-Stunden-Volumen:

97,347

Marktkapitalisierung:

$86.87M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-112.38M

KGV:

-0.6878

EPS:

-2.05

Netto-Cashflow:

$-83.38M

1W Leistung:

+8.46%

1M Leistung:

-1.40%

6M Leistung:

+111.20%

1J Leistung:

+36.89%

1-Tages-Spanne:

$1.25

$1.45

52-Wochen-Spanne:

$0.5751

$1.79

Passage Bio Inc Stock (PASG) Company Profile

Firmenname

Passage Bio Inc

Sektor

Healthcare (1215)

Branche

Biotechnology (700)

Telefon

267 866 0311

Adresse

One Commerce Square, 39th Floor 2005 Market Street, Philadelphia, PA

Mitarbeiter

133

Twitter

@passage_bio

Nächster Verdiensttermin

2024-05-21

Neueste SEC-Einreichungen

PASG's Discussions on Twitter

Passage Bio Inc Stock (PASG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-03-08	Herabstufung	JP Morgan	Overweight → Neutral
2022-01-19	Herabstufung	Goldman	Buy → Neutral
2021-07-01	Eingeleitet	Raymond James	Outperform
2021-06-15	Eingeleitet	BTIG Research	Buy
2021-03-04	Hochstufung	Goldman	Neutral → Buy
2021-02-04	Eingeleitet	Guggenheim	Buy
2021-01-25	Eingeleitet	Wedbush	Outperform
2021-01-04	Hochstufung	JP Morgan	Neutral → Overweight
2020-12-11	Eingeleitet	Citigroup	Neutral
2020-08-14	Herabstufung	JP Morgan	Overweight → Neutral
2020-06-25	Herabstufung	Goldman	Buy → Neutral
2020-03-25	Eingeleitet	Chardan Capital Markets	Buy
2020-03-24	Eingeleitet	Cowen	Outperform
2020-03-24	Eingeleitet	Goldman	Buy
2020-03-24	Eingeleitet	JP Morgan	Overweight

Alle ansehen

Passage Bio Inc Aktie (PASG) Neueste Nachrichten

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

GlobeNewswire Inc.

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights

GlobeNewswire Inc.

Passage Bio to Participate in Upcoming Investor Conferences

GlobeNewswire Inc.

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire Inc.

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket

Benzinga

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities

GlobeNewswire Inc.

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Passage Bio Inc (PASG) Nettogewinn 2024

Passage Bio Inc (PASG) Free Cashflow 2024

Passage Bio Inc (PASG) Gewinn je Aktie 2024